|
Microvascular Rarefaction
|
C23.300.818 |
|
|
Leukoplakia
|
C23.300.816 |
|
|
Uroporphyrinogen III Synthetase
|
D08.811.520.241.300.950 |
|
|
Alarmins
|
D23.035 |
|
|
Event-Related Potentials, P300
|
G11.561.200.500.350 |
|
|
Mineral Fibers
|
D01.578.500 |
|
|
Sex Factors
|
N06.850.490.875 |
|
|
Adamantane
|
D02.455.426.100.050 |
|
|
Medical Office Buildings
|
N02.278.562 |
|
|
Germinal Center
|
A10.549.400.500 |
|
|
Hip Dislocation
|
C05.550.518.384 |
|
|
Tolcapone
|
D02.455.426.559.389.134.875 |
|
|
Laryngeal Mucosa
|
A04.760.520 |
|
|
Warburg Effect, Oncologic
|
G02.111.158.750.500 |
|
|
Glycolysis
|
G02.111.158.750 |
|
|
Chlorothiazide
|
D02.886.655.500.261 |
|
|
Multifactorial Inheritance
|
G05.420.590 |
|
|
Silver-Russell Syndrome
|
C16.131.260.870 |
|
|
Bradykinin
|
D12.644.276.812.169 |
|
|
Extensively Drug-Resistant Tuberculosis
|
C01.150.252.410.040.552.846.775.500 |
|
